Clinical Trial Update: The Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients With Bicuspid Aortic Stenosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing safety and effectiveness of Transcatheter Aortic Valve Raplacemet in intermediate-risk patients with bicuspid aortic ste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease

Drugs mentioned

• Raplacemet (Raplacemet)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Aortic Valve Disease | Phase 2 | Status: UNKNOWN